Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
fabio.pulcinelli@uniroma1.it
Fabio Maria Pulcinelli
Professore Ordinario
Struttura:
DIPARTIMENTO DI MEDICINA SPERIMENTALE
E-mail:
fabio.pulcinelli@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Platelet activation and multidrug resistance protein-4 expression in children and adolescents with different subtypes of primary thrombocythemia
HAEMATOLOGICA
2020
Platelet and megakaryocyte CD40L expression in β-Thalassemic patients
THROMBOSIS RESEARCH
2020
Cilostazol reduces cerebrovascular risk through the inhibition of multi-drug resistance protein 4/ATP binding cassette subfamily C member 4
EXPERT OPINION ON PHARMACOTHERAPY
2020
Effect of low or high doses of low‐molecular‐weight heparin on thrombin generation and other haemostasis parameters in critically ill patients with COVID‐19
BRITISH JOURNAL OF HAEMATOLOGY
2020
MRP4 over-expression has a role on both reducing nitric oxide-dependent antiplatelet effect and enhancing ADP induced platelet activation
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
2020
Effect of low or high doses of low-molecular-weight heparin on thrombin generation and other haemostasis parameters in critically ill patients with COVID-19
BRITISH JOURNAL OF HAEMATOLOGY
2020
Aspirin-dependent effects on purinergic P2Y1 receptor express
THROMBOSIS AND HAEMOSTASIS
2019
Early Aspirin Nonresponders Identification by Routine Use of Aggregometry Test in Patients With Left Ventricle Assist Devices Reduces the Risk of Pump Thrombosis
TRANSPLANTATION PROCEEDINGS
2019
Medicina di laboratorio - La diagnosi di malattia nel laboratorio clinico: collaborazione traduzione
Medicina di laboratorio
2019
Impact of Multidrug Resistance Protein-4 Inhibitors on Modulating Platelet Function and High on-Aspirin Treatment Platelet Reactivity
THROMBOSIS AND HAEMOSTASIS
2018
From human Megakaryocytes to platelets: Effects of aspirin on high-mobility group Box 1/receptor for advanced glycation end products axis
FRONTIERS IN IMMUNOLOGY
2018
MiR-21 role in aspirin-dependent PPARα and MRP4 up-regulation
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS
2018
Platelet miRNA-26b down-regulates multidrug resistance protein 4 in patients on chronic aspirin treatment
JOURNAL OF CARDIOVASCULAR MEDICINE
2018
New platelet functional method for identification of pathogenic antibodies in HIT patients
PLATELETS
2017
Enhanced platelet MRP4 expression and correlation with platelet function in patients under chronic aspirin treatment
THROMBOSIS AND HAEMOSTASIS
2016
Letter by Iannuccelli et al Regarding Article, "paracetamol, Ibuprofen, and Recurrent Major Cardiovascular and Major Bleeding Events in 19 120 Patients with Recent Ischemic Stroke"
STROKE
2016
Aspirin Treatment and Outcomes After Percutaneous Coronary Intervention: Results of the ISAR-ASPI Registry
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
2015
Multidrug Resistance Protein-4 influences aspirin toxicity in human cell line
MEDIATORS OF INFLAMMATION
2015
Arachidonic acid-stimulated platelet tests: Identification of patients less sensitive to aspirin treatment
PLATELETS
2015
Dual Antiplatelet Therapy in Neuroendovascular Procedures
Frontiers in Neurosurgery: NeuroEndovascular Challenges
2015
« prima
< precedente
1
2
3
seguente ›
ultima »
Progetti di Ricerca
Identificazione di pazienti a rischio per endometriosi mediante dosaggio plasmatico di MRP4.
Dosaggio di MRP4 piastrinico in pazienti in trattamento cronico con aspirina
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma